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ogreat deal of hype and excitement accompa-
nied the advent of catheter-based magnetic
resonance imaging (MRI) of the vessel
wall at the end of the 1990s. Initial
tudies were performed in the vessels ex vivo that
emonstrated excellent correlation with histologi-
al characteristics of the imaged plaques (1–3). A
roblem arose that once the catheter was inserted
n an artery, motion degraded the image quality.
he imaging volume accessible to the receiver
oil on the end of the catheter was limited in
cope and prohibited a large enough field-of-
iew for imaging the entire vessel wall. In addi-
ion, image acquisition required several min-
tes. All of the above limitations precluded
pplication in the clinical setting at that time.
lthough some inroads were then made to in
ivo imaging in human iliac arteries, and the
esults compared favorably to intravascular ul-
rasound, the MRI characterization was limited
o calcified and noncalcified plaques (4). The
ccuracy for identification of lipid and fibrous
omponents of plaque was modest at best. As im-
ging from the surface of the body improved, the
mpetus to use an invasive device to image plaque
ppeared to wane. Surface imaging has allowed
xcellent characterization of plaque morphology in
he aorta (5), carotid arteries (6), and peripheral
asculature (7). However, because surface MRI
oes not offer the spatial resolution to adequately
haracterize plaque in the coronary arteries, inter-
st in catheter-based approaches has re-emerged.
In this issue of iJACC, Sathyanarayana et al. (8)
resent the advances in catheter-based imaging
rom the *University of Virginia Health System, Charlottesville, Virginia;t
nd the †University of California, Irvine, California. Dr. Kramer is
upported by NIH R01 HL075792.ith MRI; the major improvements include greater
peed of acquisition and higher spatial resolution.
mages were acquired at several frames per second
r near real-time, and the spatial resolution ap-
roached 300  adjustable down to 80 . At this
esolution, one is almost at the level that imaging
f the fibrous cap may become feasible in human
oronary arteries. Proof of principle has been pro-
ided in ex vivo human iliac arteries as well as in
ivo in a rabbit model of atherosclerosis. Imaging
istance from the coil was as large as a 4 mm ra-
ius. One of the underlying reasons for these ad-
ances is the move to higher field strengths, in
his case 3.0-T, which allowed a 4-fold increase
n signal to noise ratio. Theoretically, even higher
eld strengths, such as 7.0-T, could be used; these
re coming into clinical fruition and are in the initial
tages of testing for cardiovascular applications.
The real application here is in the coronary ar-
eries, as surface imaging by MRI of the vascular
all in other beds has come a long way with spe-
ialized surface coils and high-resolution black
lood imaging techniques. It is not likely that we
ill be able to approach the necessary spatial res-
lution for coronary arteries anytime soon without
ntravascular imaging. So, in the coronary arteries,
ill MRI offer more information than the avail-
ble intravascular techniques? The answer is prob-
bly yes and no. Intravascular MRI will have a
etter resolution and characterization capability
han the ultrasound, but 1-10  optical coherence
omography-verified cap morphology and mea-
urement of thickness cannot be bettered. Unlike
lectrophysiology and noncardiac applications,
here has been little interaction between coronary
nterventionalists and MRI experts. There are
nly a handful of laboratories around the world
hat are working on that interface. The critical
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Editor’s Page
1204ass of research in this arena will need to in-
rease to be able to push the field further. In ad-
ition, availability of MRI-compatible catheters
nd devices would need to improve to push the
eld forward.
So, where are we headed with this form of im-
ging? Is it a precursor to the real deal and a pro-
edure that will become clinically feasible within
he next decade, or are we heading down a blind
ath with no end? The answer probably lies some-
here in-between. The technological advances that
ave allowed these observations occurred in a highly
pecialized center with exceedingly sophisticated
RI know-how and technological capabilities. A
ew technique will need to compete with other
ntravascular technologies. In the end though, the
andle must be worth the wick. We have not
roven that characterizing coronary atherosclerosiscular magnetic resonance imaging spectral magnetic rient outcome. We know from a number of stud-
es in coronaries and other vascular beds that the
hickness and intact state of the fibrous cap and
resence of hemorrhage within the plaque can
redict subsequent events. We do not know that
dentifying these components and treating them
arlier would make a difference in patient out-
ome. Until we do, this will be an area of con-
ecture and debate. And, even if we demon-
trated the importance of plaque characterization,
e do not as of yet have specific intervention
trategy except the statin and stent shotgun.
hat the current presentation represents is an-
ther success story in the field of imaging and a
tep forward to be able to understand progres-
ion of atherosclerosis in vivo in humans. It is
ur sincere hope that it will help develop supe-
ior management strategies for the conquest ofin vivo will make a difference in therapies or pa- an elusive malady.7
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